Royce & Associates’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-40,000
| Closed | -$680K | – | 1195 |
|
|
2019
Q3 | $680K | Sell |
40,000
-37,000
| -48% | -$629K | 0.01% | 861 |
|
|
2019
Q2 | $1.75M | Hold |
77,000
| – | – | 0.02% | 750 |
|
|
2019
Q1 | $2.48M | Sell |
77,000
-23,000
| -23% | -$740K | 0.02% | 679 |
|
|
2018
Q4 | $2.82M | Hold |
100,000
| – | – | 0.03% | 630 |
|
|
2018
Q3 | $2.88M | Buy |
100,000
+74,000
| +285% | +$2.13M | 0.02% | 740 |
|
|
2018
Q2 | $974K | Sell |
26,000
-59,000
| -69% | -$2.21M | 0.01% | 947 |
|
|
2018
Q1 | $3.34M | Sell |
85,000
-9,000
| -10% | -$354K | 0.02% | 697 |
|
|
2017
Q4 | $3.05M | Hold |
94,000
| – | – | 0.02% | 740 |
|
|
2017
Q3 | $2.93M | Hold |
94,000
| – | – | 0.02% | 734 |
|
|
2017
Q2 | $2.63M | Hold |
94,000
| – | – | 0.02% | 778 |
|
|
2017
Q1 | $1.61M | Sell |
94,000
-186,800
| -67% | -$3.2M | 0.01% | 909 |
|
|
2016
Q4 | $3.4M | Sell |
280,800
-180,000
| -39% | -$2.18M | 0.02% | 682 |
|
|
2016
Q3 | $7.3M | Sell |
460,800
-73,000
| -14% | -$1.16M | 0.05% | 468 |
|
|
2016
Q2 | $6.9M | Buy |
533,800
+183,400
| +52% | +$2.37M | 0.05% | 492 |
|
|
2016
Q1 | $6.66M | Sell |
350,400
-70,000
| -17% | -$1.33M | 0.04% | 518 |
|
|
2015
Q4 | $9.46M | Buy |
420,400
+56,900
| +16% | +$1.28M | 0.06% | 426 |
|
|
2015
Q3 | $8.51M | Sell |
363,500
-63,100
| -15% | -$1.48M | 0.05% | 497 |
|
|
2015
Q2 | $12.2M | Buy |
426,600
+75,000
| +21% | +$2.15M | 0.05% | 469 |
|
|
2015
Q1 | $9.08M | Buy |
351,600
+26,600
| +8% | +$687K | 0.03% | 608 |
|
|
2014
Q4 | $6.03M | Hold |
325,000
| – | – | 0.02% | 742 |
|
|
2014
Q3 | $5.04M | Buy |
+325,000
| New | +$5.04M | 0.02% | 815 |
|